Global Botulinum Toxin Market: Size, Trends and Forecasts Through 2018-2022, with Profiles for Allergan, Ipsen and Revance -
Tuesday, 01 January 2019 20:06
Jan. 2, 2019 17:12 UTC

Global Botulinum Toxin Market: Size, Trends and Forecasts Through 2018-2022, with Profiles for Allergan, Ipsen and Revance -

DUBLIN--(BUSINESS WIRE)-- The "Global Botulinum Toxin Market: Size, Trends and Forecasts (2018-2022 Edition)" report has been added to's offering.

The global botulinum toxin market has increased at a significant annual growth rate in 2017 as compared to the preceding year 2016, and projections are made that the market will rise in the next five years i.e. 2018-2022 tremendously.

The upsurge in the market was due to various factors such as increased patient comfort, shorter procedure times and immediate results. The market can be segmented on the basis of application as therapeutics and cosmetic/aesthetic, of which therapeutics govern the market.

The major growth drivers for the botulinum toxin market are: aging population, escalating numbers of surgeons, upsurge in facial aesthetics procedures, rising alternative of non-surgical procedures, increasing healthcare spending in emerging markets.

Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as potential health risk associated with botulinum toxin and botulinum toxins as bio-terror threat.

Rise in medical tourism, reduced safety concerns and simple and instant characteristic and scope of botulinum toxin in treatment of Necrotizing Fasciitis are some of the latest trends existing in the market.

The competition in the global botulinum toxin market is stiff and dominated by big players like Allergan. Further, key players of the botulinum toxin market Ipsen and Revance are also profiled with their financial information and respective business strategies.

Key Topics Covered

1. Executive Summary

2. Introduction

3. Global Market Analysis

4. Regional Market Analysis

5. Market Dynamics

6. Competitive Landscape

7. Company Profiles

  • Allergan PLC
  • Ipsen
  • Revance Therapeutics Inc.

For more information about this report visit

Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs

Source: Research and Markets

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit!! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!